enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Amgen - Wikipedia

   en.wikipedia.org/wiki/Amgen

   AMGen corporate logo, 1983 Argentine president Mauricio Macri meets with heads of Amgen, in 2018. Amgen was established in Thousand Oaks in 1980, as Applied Molecular Genetics. [6] [7] Amgen was backed by a small group of venture capitalists, and its early focus was on recombinant DNA technology and recombinant human insulin. [8]

3. Amgen Seeks Expanded US Approval For Autoimmune Disease ... - AOL

   www.aol.com/amgen-seeks-expanded-us-approval...

   Amgen added Uplizna via a $27.8 billion acquisition of Horizon Therapeutics and recorded sales of $80 million in the first quarter of 2024. The trial met its primary endpoint, showing a ...

4. Apremilast - Wikipedia

   en.wikipedia.org/wiki/Apremilast

   In 2019, Amgen acquired Otezla from Celgene for $13.4 billion. [27] [28] In 2020, Otezla generated $2.2 billion for Amgen. [29] Apremilast was listed on the PBS in Australia in January 2021, for chronic plaque psoriasis. [30]

5. Bradley Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Bradley_Pharmaceuticals

   Bradley Pharmaceuticals comprised Doak Dermatologics, specialized in therapies for dermatology and podiatry; Kenwood Therapeutics, providing gastroenterology, OB/GYN and other internal medicine brands; and A. Aarons, which markets authorized generic versions of Doak and Kenwood therapies.

6. US FDA approves Amgen's biosimilar to AstraZeneca's rare ...

   www.aol.com/news/us-fda-approves-amgens-bio...

   Amgen's drug will be marketed under the name Bkemv. Biosimilars are close copies of complex biological drugs. In 2022, the company said that Bkemv met the main goal of a late stage study, where ...

7. Amgen/Allergan Get FDA Nod for Herceptin Biosimilar Kanjinti

   www.aol.com/news/amgen-allergan-fda-nod...

   For premium support please call: 800-290-4726 more ways to reach us

8. Actavis - Wikipedia

   en.wikipedia.org/wiki/Actavis

   Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.

9. Amgen's Catching Up to Novo Nordisk and Eli Lilly ... - AOL

   www.aol.com/amgens-catching-novo-nordisk-eli...

   Amgen's entrant in the weight-loss drug gold rush is called MariTide, and it's currently in phase 2 clinical trials. Thanks to how favorable the preliminary phase 2 data is, management is already ...